Autopsy-Confirmed Parkinson Disease GWAS Consortium (APDGC)

ABSTRACT:

The APDGC was formed to conduct a genome-wide association study in individuals with neuropathologically confirmed Parkinson Disease (PD) and neuropathologically normal controls. The rationale for the study is that including only cases and controls with neuropathologically confirmed disease status will reduce diagnostic misclassification and increase power to detect novel genetic associations.

PROVIDER: phs000394 | dbGaP |

SECONDARY ACCESSION(S): PRJNA76007PRJNA76005

REPOSITORIES: dbGaP